187 related articles for article (PubMed ID: 25956997)
1. Synthesis and evaluation of 4-[18F]fluoropropoxy-3-iodobenzylguanidine ([18F]FPOIBG): A novel 18F-labeled analogue of MIBG.
Vaidyanathan G; McDougald D; Koumarianou E; Choi J; Hens M; Zalutsky MR
Nucl Med Biol; 2015 Aug; 42(8):673-84. PubMed ID: 25956997
[TBL] [Abstract][Full Text] [Related]
2. Retention Kinetics of the 18F-Labeled Sympathetic Nerve PET Tracer LMI1195: Comparison with 11C-Hydroxyephedrine and 123I-MIBG.
Werner RA; Rischpler C; Onthank D; Lapa C; Robinson S; Samnick S; Javadi M; Schwaiger M; Nekolla SG; Higuchi T
J Nucl Med; 2015 Sep; 56(9):1429-33. PubMed ID: 26182969
[TBL] [Abstract][Full Text] [Related]
3. Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG.
Zhang H; Huang R; Cheung NK; Guo H; Zanzonico PB; Thaler HT; Lewis JS; Blasberg RG
Clin Cancer Res; 2014 Apr; 20(8):2182-91. PubMed ID: 24573553
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of 18F-labeled benzylguanidine analogs for targeting the human norepinephrine transporter.
Zhang H; Huang R; Pillarsetty N; Thorek DL; Vaidyanathan G; Serganova I; Blasberg RG; Lewis JS
Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):322-32. PubMed ID: 24173571
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of LMI1195, a novel 18F-labeled cardiac neuronal PET imaging agent, in cells and animal models.
Yu M; Bozek J; Lamoy M; Guaraldi M; Silva P; Kagan M; Yalamanchili P; Onthank D; Mistry M; Lazewatsky J; Broekema M; Radeke H; Purohit A; Cdebaca M; Azure M; Cesati R; Casebier D; Robinson SP
Circ Cardiovasc Imaging; 2011 Jul; 4(4):435-43. PubMed ID: 21555377
[TBL] [Abstract][Full Text] [Related]
6. Novel [
Li X; Shi S; Zhou H; Zhao Z; Lu J
Mol Pharm; 2021 Oct; 18(10):3811-3819. PubMed ID: 34519204
[TBL] [Abstract][Full Text] [Related]
7. No-carrier-added iodine-131-FIBG: evaluation of an MIBG analog.
Vaidyanathan G; Zhao XG; Strickland DK; Zalutsky MR
J Nucl Med; 1997 Feb; 38(2):330-4. PubMed ID: 9025764
[TBL] [Abstract][Full Text] [Related]
8. A 4-methyl-substituted meta-iodobenzylguanidine analogue with prolonged retention in human neuroblastoma cells.
Vaidyanathan G; Welsh PC; Vitorello KC; Snyder S; Friedman HS; Zalutsky MR
Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1362-70. PubMed ID: 15205923
[TBL] [Abstract][Full Text] [Related]
9. 3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells.
Vaidyanathan G; Zhao XG; Larsen RH; Zalutsky MR
Br J Cancer; 1997; 76(2):226-33. PubMed ID: 9231923
[TBL] [Abstract][Full Text] [Related]
10. Radiolabeled (4-Fluoro-3-Iodobenzyl)Guanidine Improves Imaging and Targeted Radionuclide Therapy of Norepinephrine Transporter-Expressing Tumors.
Yamaguchi A; Hanaoka H; Higuchi T; Tsushima Y
J Nucl Med; 2018 May; 59(5):815-821. PubMed ID: 29217738
[No Abstract] [Full Text] [Related]
11. Potential and practical adrenomedullary PET radiopharmaceuticals as an alternative to m-iodobenzylguanidine: m-(omega-[18F]fluoroalkyl)benzylguanidines.
Lee BC; Paik JY; Chi DY; Lee KH; Choe YS
Bioconjug Chem; 2004; 15(1):104-11. PubMed ID: 14733589
[TBL] [Abstract][Full Text] [Related]
12. Validation of 4-[fluorine-18]fluoro-3-iodobenzylguanidine as a positron-emitting analog of MIBG.
Vaidyanathan G; Affleck DJ; Zalutsky MR
J Nucl Med; 1995 Apr; 36(4):644-50. PubMed ID: 7699460
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of
Das S; Sakhare N; Mathur A; Mallia MB; Mirapurkar S; Sheela M; Sarma HD; Sachdev SS; Dash A
Nucl Med Biol; 2019; 68-69():49-57. PubMed ID: 30770228
[TBL] [Abstract][Full Text] [Related]
14. No-carrier-added synthesis of meta-[131I]iodobenzylguanidine.
Vaidyanathan G; Zalutsky MR
Appl Radiat Isot; 1993 Mar; 44(3):621-8. PubMed ID: 8472027
[TBL] [Abstract][Full Text] [Related]
15. (4-[18F]fluoro-3-iodobenzyl)guanidine, a potential MIBG analogue for positron emission tomography.
Vaidyanathan G; Affleck DJ; Zalutsky MR
J Med Chem; 1994 Oct; 37(21):3655-62. PubMed ID: 7932592
[TBL] [Abstract][Full Text] [Related]
16. No-carrier-added synthesis of a 4-methyl-substituted meta-iodobenzylguanidine analogue.
Vaidyanathan G; Affleck DJ; Zalutsky MR
Appl Radiat Isot; 2005 Mar; 62(3):435-40. PubMed ID: 15607920
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo studies with no-carrier added radioiodinated MIBG.
Franceschini R; Pecorale A; Chinol M; Calcagni ML; Servidei T; Riccardi R; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):72-7. PubMed ID: 9002755
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of 18F-LMI1195 for in vivo imaging of pheochromocytoma in the MENX tumor model.
Gaertner FC; Wiedemann T; Yousefi BH; Lee M; Repokis I; Higuchi T; Nekolla SG; Yu M; Robinson S; Schwaiger M; Pellegata NS
J Nucl Med; 2013 Dec; 54(12):2111-7. PubMed ID: 24136933
[TBL] [Abstract][Full Text] [Related]
19. Initial Evaluation of AF78: a Rationally Designed Fluorine-18-Labelled PET Radiotracer Targeting Norepinephrine Transporter.
Chen X; Fritz A; Werner RA; Nose N; Yagi Y; Kimura H; Rowe SP; Koshino K; Decker M; Higuchi T
Mol Imaging Biol; 2020 Jun; 22(3):602-611. PubMed ID: 31332629
[TBL] [Abstract][Full Text] [Related]
20. Iodopyridine-for-iodobenzene substitution for use with low molecular weight radiopharmaceuticals: application to m-iodobenzylguanidine.
Vaidyanathan G; Zalutsky MR; DeGrado TR
Bioconjug Chem; 1998; 9(6):758-64. PubMed ID: 9815170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
